Arama

ISSN 2147-9720

EISSN 2148-4279

EJR IS INDEXED IN WEB OF SCIENCE AND PUBMED CENTRAL

European Journal of Rheumatology

PDF

HIGHLY CITED ARTICLES

An overview and management of osteoporosis

By: Sozen, Tumay; Ozisik, Lale; Basaran, Nursel Calik

Updates in ANCA-associated vasculitis

By: Pagnoux, Christian

The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus

By: Unlu, Ozan; Zuily, Stephane; Erkan, Doruk

Low vitamin D status in systemic sclerosis and the impact on disease phenotype

By: Groseanu, Laura; Bojinca, Violeta; Gudu, Tania; et al.

Sarcopenia in women with rheumatoid arthritis

By: Dogan, Sevil Ceyhan; Hizmetli, Sami; Hayta, Emrullah; et al.

The endocannabinoid system in pain and inflammation: Its relevance to rheumatic disease

By: Barrie, Nicola; Manolios, Nicholas

Recent advances in Takayasu's arteritis

By: Alibaz-Oner, Fatma; Aydin, Sibel Zehra; Direskeneli, Haner

IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: Evidence for a dual role

By: Raymond, Warren; Ostli-Eilertsen, Gro; Griffiths, Sheynae; et al.

Prevalence of metabolic syndrome and degree of cardiovascular disease risk in patients with Psoriatic Arthritis

By: Ozkan, Sidika Gulkan; Yazisiz, Hatice; Behlul, Ahmet; et al.

Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 13 results

Ranking

Release Date Sort Sort Article Type

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Amr H. Sawalha, Susan Manzi

(Eur J Rheumatol 2020; 7: S117-S120) DOI: 10.5152/eurjrheum.2020.20055

Abstract Full Text (PDF) Related Articles

Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China

Yu Liu, Christopher Chang, Qianjin Lu

(Eur J Rheumatol 2020; 7: S94-S96) DOI: 10.5152/eurjrheum.2020.2056

Abstract Full Text (PDF) Related Articles

Being a rheumatologist and a patient with a rheumatic disease today: A perspective at the time of COVID-19

Carlo Perricone, Roberto Gerli

(Eur J Rheumatol 2020; 7: S89-S90) DOI: 10.5152/eurjrheum.2020.2057

Abstract Full Text (PDF) Related Articles

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China

Being a rheumatologist and a patient with a rheumatic disease today: A perspective at the time of COVID-19

The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia

Egypt’s groundwork blessing during the COVID-19 pandemic curse: Rheumatologic experience

Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists

The emerging role of lung ultrasound in COVID-19 pneumonia

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Hydroxychloroquine against COVID-19: A critical appraisal of the existing evidence

A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics

Coronavirus 2019 outbreak pathogenesis: Why China and Italy?

Conducting research in a pandemic: The power of social media

Immunotherapy for ANCA-associated vasculitis during the COVID-19 pandemic